Stay updated with breaking news from Cellular Dynamics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BlueRock Therapeutics, a Bayer subsidiary, is teaming up with Opsis Therapeutics and Fujifilm Cellular Dynamics in an R&D pact focused on developing stem cell therapies for eye diseases. BlueRock is paying its new partners $30 million up front to kick off the alliance.
Launched during the pandemic, a team-based experience opens doors to students’ success Biochemistry and molecular biology students taking BMB 490 write down their observations of cells while in the tissue culture room.Image: Emily Bell, Penn State A new approach to undergraduate research Seth Palmer April 01, 2021 UNIVERSITY PARK, Pa. — Having to turn students away from the lab just didn’t sit well with professor Emily Bell. “We know that being involved in research is a really valuable and important experience for students,” she said. “It changes the way they think about science, ...
4.3.6 The Next Five Years 5. Cell Based Assays Recent Developments 5.1 Recent Developments - Importance and How to Use This Section 5.1.1 Importance of These Developments 5.1.2 How to Use This Section Axxam and FUJIFILM Cellular Dynamics Announce Strategic Alliance Cancer Genetics to Acquire Organoid Startup Stemonix Curi Bio Acquires Artificial Intelligence Firm Dana Solutions CRISPR Screens Uncover Novel Cancer Therapy Targets ERS Genomics Licenses CRISPR-Cas9 Patents to Axxam New Transcriptomics Assay Facilitates Compound Screens Carta Biosciences Betting on Gene Interaction Mappi...